The global drug device combination products market is expected to reach $115.1 billion by 2019, growing at a compound annual growth rate of 7.9 percent, according to a news release.
In 2012, the market was valued at $66 billion.
Drug device combination products combine a drug and medical device to be produced as a single product, such as infusion pumps, inhalers, coronary stents and intraocular implants.
The growing elderly population is contributing to the rise in demand for drug device combination products, according to the report.
More Articles on Medical Device Markets:
Infection Control Market Expected to Reach $14B by 2017
Global Medical Device Packaging Market to Reach $26B by 2017
Medical Bionic Implant Market to Hit $18B by 2017